Nonrandomized Comparison of Adverse Events Following Facility- and Home-Infused Biologics Using Real-World Data
JAMA Netw Open
.
2021 Jun 1;4(6):e2111156.
doi: 10.1001/jamanetworkopen.2021.11156.
Authors
Gregory S Calip
1
2
,
Prakirthi Yerram
1
,
Mustafa S Ascha
1
Affiliations
1
Flatiron Health Inc, New York, New York.
2
University of Illinois at Chicago, College of Pharmacy, Chicago.
PMID:
34081142
DOI:
10.1001/jamanetworkopen.2021.11156
No abstract available
Publication types
Comment
MeSH terms
Antirheumatic Agents* / therapeutic use
Arthritis, Rheumatoid* / drug therapy
Biological Products* / adverse effects
Humans
Substances
Antirheumatic Agents
Biological Products